跳至主要内容
临床试验/NCT05589584
NCT05589584已完成3 期

Effect of N-acetyl Cysteine on Markers of Oxidative Stress and Insulin Resistance in Patients with Non-alcoholic Fatty Liver Disease

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
60
试验地点
1
主要终点
assessment of the effect of NAC on leptin

研究概览

简要总结

Effect of N-acetyl cysteine on markers of oxidative stress and insulin resistance in patients with Non-alcoholic fatty liver disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females aged 18-60 years diagnosed with NAFLD

排除标准

  • History of alcohol consumption, drug addiction or the use of medications known to precipitate steatohepatitis.
  • Patients with schistosomiasis, active hepatitis B or C, autoimmune and diabetes mellitus.
  • current Consumption of any antioxidant supplements and hepatotoxic drug.
  • Pregnancy or lactation or expecting to get pregnant during the study.
  • Medical, psychological, or pharmacological factors interfering with the collection or interpretation of study data.
  • Active Cancer patients.
  • Anyone having hypersensitivity to N-acetylcysteine.
  • Anyone already taking N-acetylcysteine.

研究组 & 干预措施

intervention

Experimental

NAC and weight reduction program

干预措施: N acetyl cysteine with weight reduction (Drug)

结局指标

主要结局

assessment of the effect of NAC on leptin

时间窗: 3 months

leptin as insulin resistance marker in NAFLD

次要结局

  • assessment of the effect of NAC on MDA(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa Mohammad Ramadan

hospital pharmacist

Ain Shams University

研究点 (1)

Loading locations...

相似试验